Skip to content

Lower Limb Movement

Read the Evidence

The STIMO study demonstrated the ability of this therapy to enable long-paralyzed people to stand and walk again with little or no assistance.

We received FDA Breakthrough Device Designation for ARCIM in 2020 to restore leg motor function in people with spinal cord injury. Then in 2021, for the use of the system to normalize blood pressure and provide trunk stability, in 2022 for bladder control, and in 2023 for reduced spasticity.

Other potential indications we may explore include improved sexual function and bowel control, and Parkinson’s mobility and gait.

Learn more

Please complete this form to
contact us or receive updates

Complete form
The ONWARD® Medical ARCEX® System is cleared for use only in the United States. ONWARD ARCIM® and ARCBCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

Join the Movement

Contact

©2025 ONWARD Medical. All rights reserved.